The May Measurement Month campaign involves volunteers who conduct blood pressure measurement camps in local communities, and the collected data is used to raise awareness and advocate for better hypertension management policies. The campaign has been successful in screening millions of people globally and has helped to increase awareness about the dangers of high blood pressure. The campaign is still ongoing, and more countries are joining every year to help reduce the global burden of hypertension. The campaign has also adapted to the COVID-19 pandemic by introducing online blood pressure measurement options and expanding its reach through digital platforms.
In May, June, and July 2023, CCDC hosted a series of impactful May Measurement Month camps across India screening 175,000 individuals for high blood pressure. These engaging events took place at various locations, showcasing the collaborative efforts of our volunteers and the individuals who participated in the screenings.
The campaigns were conducted in diverse settings including old age homes, clinics, hospitals, schools, and religious places across several cities and regions such as Meerut, Pune, Kolkata, Bangalore, Mumbai, J&K, Indore, Bhopal, Lucknow, Ahmedabad, Delhi, Chandigarh, Prayagraj, Nashik, Nagpur, Chennai, Puducherry, Kochi, Imphal, Shimla, Haryana, Uttarakhand, and various villages in Punjab.
Over 20 in-person and online training sessions were organized for both physicians and non-physicians, resulting in more than 350 volunteers actively participating in the campaign.
The objectives of the May Measurement Month 2023 campaign were:
- To screen at least 1 million individuals aged ≥ 18 years for blood pressure.
- To provide dietary and lifestyle advice to those with blood pressure in the high normal (130-139 / 80-89 mmHg) and hypertensive (>140/90mmHg) ranges.
- To offer guidance on further follow-up for individuals with elevated blood pressure based on local healthcare resources.
- To utilize data on untreated and inadequately treated hypertension to advocate for improvements in local screening facilities and policies, aiming to reduce the global burden associated with high blood pressure.
